Books

Ian Harper’s Development and Public Health in the Himalaya

Harper - Cover

Ian Harper, Professor of Anthropology, Health, and Development at the University of Edinburgh, talks to Alice Street about his book Development and Public Health in the Himalaya: Reflections on Healing in Contemporary Nepal.

 

AS: Ian, maybe you can tell us a little bit about your history as a medical practitioner, and how you came to work in Nepal.

IH: …

Books

Jonathan Xavier Inda’s Racial Prescriptions

PPCspine22mmRacial Prescriptions: Pharmaceuticals, Difference, and the Politics of Life

by Jonathan Xavier Inda

Ashgate, 2014, 148 pages.

 

Racial Prescriptions provides an eloquent and theoretically-engaged account of the story of BiDil, a pharmaceutical that has become an iconic case for scholars of race in science and medicine. When BiDil was approved by the U.S. Food and Drug Administration (FDA) in …

Books

Kristin Peterson’s Speculative Markets

978-0-8223-5702-5_prSpeculative Markets: Drug Circuits and Derivative Lives in Nigeria

by Kristin Peterson

Duke University Press, 2014, 264 pages.

 

In her remarkable book, Speculative Markets: Drug Circuits and Derivative Lives in Nigeria, Kristin Peterson sets out to explore and resituate the pharmaceutical industry, and pharmaceutical markets, in Nigeria. The outcome is a highly-detailed, carefully analyzed and enlightening piece of …

BooksFeatures

Book Forum––Introduction, Jeremy Greene’s “Generic”

This article is part of the series:

Welcome to our inaugural “Book Forum.”  Our aim is simple: to promote lively exchange between a group of scholars and an author, allowing for experimental and inventive engagements that are not so much about evaluation but rather draw on concepts and shared commitments.  It’s probably worth noting that Somatosphere will continue to feature book reviews, which have been a mainstay …

Books

Joseph Dumit’s Drugs for Life

Drugs for Life: How Pharmaceutical Companies Define Our Health

by Joseph Dumit

Duke University Press, 2012. pp. 280.

Since the 1970s, scholarly work on pharmaceuticals has long engaged a number of concerns, debates and controversies: the socialities and politics of consumption, the commercialization of the life sciences, and restricted access to life-saving medicines as a result of global patent and …